Package 0615-8593-39

Brand: topiramate

Generic: topiramate
NDC Package

Package Facts

Identity

Package NDC 0615-8593-39
Digits Only 0615859339
Product NDC 0615-8593
Product ID 0615-8593_ef25c664-5229-41f1-9125-b18232e135ad
Description

30 TABLET, FILM COATED in 1 BLISTER PACK (0615-8593-39)

Marketing

Marketing Status
Marketed Since 2025-10-21
Brand topiramate
Generic topiramate
Sample Package No

Linked Drug Pages (1)

Topiramate ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "ef25c664-5229-41f1-9125-b18232e135ad", "openfda": {"nui": ["N0000008486", "N0000185506", "N0000182140"], "unii": ["0H73WJJ391"], "rxcui": ["151226", "199888", "199889"], "spl_set_id": ["444464fb-6a95-4e10-99a7-fdbc7dbb4c48"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_moa": ["Cytochrome P450 3A4 Inducers [MoA]", "Cytochrome P450 2C19 Inhibitors [MoA]"], "manufacturer_name": ["NCS HealthCare of KY, LLC dba Vangard Labs"]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, FILM COATED in 1 BLISTER PACK (0615-8593-39)", "package_ndc": "0615-8593-39", "marketing_start_date": "20251021"}], "brand_name": "Topiramate", "product_id": "0615-8593_ef25c664-5229-41f1-9125-b18232e135ad", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Cytochrome P450 2C19 Inhibitors [MoA]", "Cytochrome P450 3A4 Inducers [MoA]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "0615-8593", "generic_name": "Topiramate", "labeler_name": "NCS HealthCare of KY, LLC dba Vangard Labs", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Topiramate", "active_ingredients": [{"name": "TOPIRAMATE", "strength": "25 mg/1"}], "application_number": "ANDA078462", "marketing_category": "ANDA", "marketing_start_date": "20090327", "listing_expiration_date": "20261231"}